Subscribe
Sign In
Tag: CBT > FDA Approved Cannabis Product
Cannabis Industry Research
The Man Behind DEA’s Federal Marijuana Scam
DEA Senior Policy Adviser Matthew Strait defied presidential mandates for medical research, MMJ International Holdings claims.
January 28, 2025
Industry Headlines
Attorney General, DEA Director, Judge Under Federal Court Summons Over DEA Marijuana Policy
Despite the DEA’s policy, MMJ International is moving forward with the FDA on cannabis drug development for Huntington’s disease.
January 6, 2025
Cannabis Industry Research
Medical Marijuana Act Signed by Biden Would Hinder Research Under Rescheduling
The Medical Marijuana and Cannabidiol Research Expansion Act’s requirements would remain under Schedule III, a congressional researcher says.
September 20, 2024
Cannabis Advertising
The Complex Impact of Rescheduling Cannabis on Advertising
The penalties for advertising Schedule I drugs don’t apply to Schedule III drugs, but cannabis businesses could be left in a precarious position.
September 17, 2024
Cannabis Packaging Regulations
FTC, FDA Send Cease-and-Desist Letters to 5 Companies Selling Delta-8 THC Products Appealing to Children
The federal agencies called out the firms for putting kids’ health at risk for the sake of profit.
July 16, 2024
Legislation and Regulation
FDA Chooses LightLab 3 Cannabis Analyzer to Enhance Consumer Safety, Regulate the Industry
The administration’s decision stems from concerns associated with food-related products containing CBD and Delta-8 THC.
August 25, 2023
CBD Industry
Hemp Numbers Plummet Across the Board in 2022 USDA Acreage and Production Survey
The value of industrial hemp totaled $238 million in 2022, down 71% from $824 million in 2021.
April 28, 2023
CBD Industry
US Lawmakers Reintroduce Bipartisan Bills to Regulate CBD
The reintroduction of the measures comes after the FDA called on Congress to regulate CBD in dietary supplements, conventional foods and animal products.
March 17, 2023
Top Stories
Question: Will the FDA Take Steps to Regulate CBD This Year? Answer: Well… Maybe.
Industry stakeholders weigh in after FDA officials told reporters last month that the agency plans to review product regulations in the coming months.
January 13, 2023
Cannabis Rescheduling
Helpful, or Yet Another Hurdle?
Many industry experts agree President Joe Biden’s three-step cannabis reform plan was historic and removing the plant from the list of Controlled Substances would be ideal. But a rescheduling could make things more complex—or even a 'disaster'—for state-legal markets.
December 23, 2022
Legislation and Regulation
UPDATED: President Biden Signs Bipartisan Cannabis Research Bill
The legislation cleared its final congressional hurdle with a voice vote last month in the Senate, paving way for researchers to fully study the impacts of cannabis use.
December 2, 2022
Legislation and Regulation
National Industrial Hemp Council Urges FDA to Approve Hemp Seed for Animal Feed
The NIHC sent a letter to the FDA, calling for the federal agency to approve hemp seed as a viable feed alternative for livestock producers.
November 7, 2022
Page 1 of 2
Next Page